FMS-like tyrosine kinase 3 (FLT3)-Internal Tandem Duplication (ITD) mutations occur in 25%–30% of AML cases, and they are associated with a particularly poor prognosis (Anabtawi et al., 2025). Here, FLT3 is linked to acute myeloid leukemia.